Essential Tremor.
TL;DR
Oral pharmacotherapies, including propranolol and primidone, are mainstays of treatment, whereas DBS and focused ultrasound thalamotomy can be offered to alleviate disabling, medication-refractory tremor, while botulinum toxin injections have shown potential effectiveness for treating head and voice tremors.
📈 연도별 인용 (2025–2026) · 합계 5
OpenAlex 토픽 ·
Neurological disorders and treatments
Genetic Neurodegenerative Diseases
Parkinson's Disease Mechanisms and Treatments
Oral pharmacotherapies, including propranolol and primidone, are mainstays of treatment, whereas DBS and focused ultrasound thalamotomy can be offered to alleviate disabling, medication-refractory tre
APA
Ludy C. Shih (2025). Essential Tremor.. Continuum (Minneapolis, Minn.), 31(4), 979-999. https://doi.org/10.1212/cont.0000000000001605
MLA
Ludy C. Shih. "Essential Tremor.." Continuum (Minneapolis, Minn.), vol. 31, no. 4, 2025, pp. 979-999.
PMID
40748121
Abstract
[OBJECTIVE] Tremor is a common presenting concern and is associated with a wide range of potential etiologies. This article reviews the approach to the clinical evaluation of tremor, the diagnosis of essential tremor, differential diagnoses, and management options.
[LATEST DEVELOPMENTS] Although new investigational drugs are being studied, no medication besides propranolol has been approved by the US Food and Drug Administration (FDA) as a treatment for essential tremor. Thalamic deep brain stimulation (DBS) has been approved for use since 1997, and refinement of the stimulation target is currently being investigated. Focused ultrasound thalamotomy was approved by the FDA in 2016, and some devices with FDA approval can administer noninvasive transcutaneous afferent patterned stimulation of the median and radial nerves to treat essential tremor. Finally, botulinum toxin injections have shown potential effectiveness for treating head and voice tremors, and methods are currently being refined for potential application in the treatment of upper limb tremors.
[ESSENTIAL POINTS] Tremor is a common neurologic symptom and should be distinguished from other movement disorders that may superficially resemble tremor. In addition, essential tremor, a primary tremor disorder consisting of bilateral upper limb action tremor, is commonly misdiagnosed. A careful history and clinical examination for other neurologic findings, such as bradykinesia, dystonia, or evidence of peripheral neuropathy, can reveal potential alternative etiologies of tremor. Drug-induced tremor and metabolic disturbances should always be considered in patients with recent-onset tremor. Oral pharmacotherapies, including propranolol and primidone, are mainstays of treatment, whereas DBS and focused ultrasound thalamotomy can be offered to alleviate disabling, medication-refractory tremor. Novel oral pharmacologic agents, noninvasive stimulation for tremor, and botulinum toxin injections for hand and head tremor need further study but may serve as potential future treatment options.
[LATEST DEVELOPMENTS] Although new investigational drugs are being studied, no medication besides propranolol has been approved by the US Food and Drug Administration (FDA) as a treatment for essential tremor. Thalamic deep brain stimulation (DBS) has been approved for use since 1997, and refinement of the stimulation target is currently being investigated. Focused ultrasound thalamotomy was approved by the FDA in 2016, and some devices with FDA approval can administer noninvasive transcutaneous afferent patterned stimulation of the median and radial nerves to treat essential tremor. Finally, botulinum toxin injections have shown potential effectiveness for treating head and voice tremors, and methods are currently being refined for potential application in the treatment of upper limb tremors.
[ESSENTIAL POINTS] Tremor is a common neurologic symptom and should be distinguished from other movement disorders that may superficially resemble tremor. In addition, essential tremor, a primary tremor disorder consisting of bilateral upper limb action tremor, is commonly misdiagnosed. A careful history and clinical examination for other neurologic findings, such as bradykinesia, dystonia, or evidence of peripheral neuropathy, can reveal potential alternative etiologies of tremor. Drug-induced tremor and metabolic disturbances should always be considered in patients with recent-onset tremor. Oral pharmacotherapies, including propranolol and primidone, are mainstays of treatment, whereas DBS and focused ultrasound thalamotomy can be offered to alleviate disabling, medication-refractory tremor. Novel oral pharmacologic agents, noninvasive stimulation for tremor, and botulinum toxin injections for hand and head tremor need further study but may serve as potential future treatment options.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 시술 | botulinum toxin
|
보툴리눔독소 주사 | dict | 2 | |
| 해부 | brain
|
scispacy | 1 | ||
| 해부 | radial nerves
|
scispacy | 1 | ||
| 해부 | upper limb
|
scispacy | 1 | ||
| 해부 | bradykinesia
|
scispacy | 1 | ||
| 해부 | peripheral
|
scispacy | 1 | ||
| 해부 | Oral
|
scispacy | 1 | ||
| 약물 | propranolol
|
C0033497
propranolol
|
scispacy | 1 | |
| 약물 | primidone
|
C0033148
primidone
|
scispacy | 1 | |
| 약물 | [OBJECTIVE] Tremor
|
scispacy | 1 | ||
| 약물 | [LATEST DEVELOPMENTS
|
scispacy | 1 | ||
| 약물 | FDA
→ Food and Drug Administration
|
scispacy | 1 | ||
| 질환 | Tremor
|
C0040822
Tremor
|
scispacy | 1 | |
| 질환 | head and voice tremors
|
scispacy | 1 | ||
| 질환 | upper limb tremors
|
scispacy | 1 | ||
| 질환 | movement disorders
|
C0026650
Movement Disorders
|
scispacy | 1 | |
| 질환 | dystonia
|
C0013421
Dystonia
|
scispacy | 1 | |
| 질환 | peripheral neuropathy
|
C0031117
Peripheral Neuropathy
|
scispacy | 1 | |
| 질환 | hand and head tremor
|
scispacy | 1 | ||
| 질환 | DBS
→ deep brain stimulation
|
scispacy | 1 | ||
| 질환 | thalamotomy
|
scispacy | 1 | ||
| 질환 | head and voice
|
scispacy | 1 | ||
| 질환 | head tremor
|
scispacy | 1 |
MeSH Terms
Humans; Essential Tremor; Deep Brain Stimulation; Male; Female; Middle Aged
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
관련 논문
- Local therapeutic strategies for neurocutaneous dysesthesia: from capsaicin to cannabinoids.
- Comparative efficacy of intralesional therapies for keloid scars: a network meta-analysis.
- Adverse neurological events following botulinum toxin type A: A case series of post-injection seizures and paralysis.
- Decreased utilization of component separation techniques over time in complex abdominal wall reconstruction following introduction of preoperative botulinum toxin A.
- Current Perspectives on Pectoralis Minor Syndrome: A Narrative Review.